A phase 2, randomized, vehicle-controlled, double-blind study to explore the efficacy, pharmacodynamics and safety of topical ionic contra-viral therapy (ICVT) comprised of digoxin and furosemide in HPV-induced genital lesions of immunocompromised and immunocompetent patients.
Active, not recruitingNL-OMON46258
Cutanea Life Sciencesgenital warts / vulva dysplasia
Start: 2017-09-04Target: 48Updated: 2024-02-28